Getting old stinks, mostly because with age comes a variety of ailments. Currently, companies that develop rejuvenation biotechnology interventions have to target individual diseases to gain FDA approval. However, a recent Lifespan.io article discussed the National Institutes of Aging’s (NIA) funding of new clinical trials against aging itself. This is an important distinction because the trials are for interventions that directly affected the root causes of age-related diseases rather than the disease itself.
NIA Looks to Combat Aging with New Clinical Trials
Rather than targeting an individual disease, funding will promote broader research related to aging.
Feb 25, 2021
Recommended
Recommended
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.
REGISTER NOW & SAVE!
